AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Sees Significant Decline in Short Interest

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the recipient of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 8,300 shares, a decline of 90.5% from the January 15th total of 87,400 shares. Based on an average trading volume of 2,612,200 shares, the days-to-cover ratio is currently 0.0 days.

AXIM Biotechnologies Trading Down 9.7 %

AXIM Biotechnologies stock traded down $0.00 during trading on Thursday, hitting $0.00. The stock had a trading volume of 82,420 shares, compared to its average volume of 813,583. AXIM Biotechnologies has a 1 year low of $0.00 and a 1 year high of $0.02.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.